Children's Medical Center Corporation

University of Pittsburgh

Other

Georgia Tech Research Corporation

Paul A Rosenberg

Paul M Gallop

Larry I Benowitz

Elias Aizenman

Paul Steven Schwartz

Frances E Jensen

Christoph J Fahrni

Michael Thomas Morgan

Joseph Volpe

Elena G Sergeeva

Pamela L Follett

Hemindra Lall

A medical answering service, typically live and telephonically-based, integrated with a cloud-based telemedicine model using HIPPA compliant and encrypted communications technology to provide e-Visits between physician/providers and patients. The system provides the physicianor healthcare provider with a unique DID/phone number for their practice, as well as applicable software applications (and hardware, if required) for installation or integration with a phone dialer, texting/SMS applications, and/or email client for later contact and use. A patient calling the unique DID/phone number is received and triaged by the system, which coordinates an e-Visit in a virtual room. The e-Visit may include real time patient measurements taken from remote peripheral devices. System communications with the physician/provider and patient are conducted using up to 4 independent channels of communication.

Integrated telemedicine system

The present invention features methods and composition directed to treating neuronal injury, CNS lesion, and/or promoting axon regeneration using a phosphine sulfide-stabilized phosphine.

Compositions and methods of treating neuronal injury

The invention provides a method for treating brain or nerve injury.

Method for treating brain or nerve injury

Methods are disclosed for modulating brain damage mediated by non-NMDA ionotropic glutamate receptor antagonists, as topiramate, in conditions such as periventricular leukomalacia, cerebral palsy, mental retardation and neonatal stroke.

Methods for modulating brain damage

A method of inhibiting neuronal injury or death in a human patient comprising administering an inhibitor of enzymatic conversion of glutamine to glutamate in an amount sufficient to inhibit the conversion of glutamine to glutamate.

Controlling glutamine/glutamate related neuronal injury

A method of resisting neurological damage caused by overstimulation of the NMDA receptor of nerve cells by glutamate includes exposing the NMDA receptors to an oxidizing agent to thereby diminish overall activity of the receptors following activation by glutamate. The oxidizing agent preferably is a material selected from the group consisting of pyrroloquinoline quinone and topa hydantoin.

Method of resisting neurodegenerative disorders

An electric power transmission module has a element for supporting at least one electric conductor disposed within a three-sided housing section and rigid base. The housing section being detachably secured to the base and the housing section being a unitary member. The module may further have a disconnect switch unit integrated therewith. An electric power transmission system may be formed of a series of such modules being interconnected end to end.

Electric power transmission module

A method for resisting neurological damage caused by overstimulation of the MDA receptor of nerve cells by glutamate includes exposing the NMDA receptors to an oxidizing agent to thereby diminish overall activity of the receptors following activation by glutamate. The oxidizing agent preferably is a material selected from the group consisting of pyrroloquinoline quinone and topa hydantoin.

Growing community of inventors

Newton, MA, United States of America

Paul A Rosenberg